The Valley Desk

ArticleChinese clinical oncologyPublished

Differences in clinical outcomes based on molecular markers in glioblastoma patients treated with concurrent tumor-treating fields and chemoradiation: exploratory analysis of the SPARE trial

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University Hospital, with Jefferson Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Chinese clinical oncology
Published
Subject terms
Humans; Glioblastoma; Brain Neoplasms; Dacarbazine; Antineoplastic Agents, Alkylating; DNA Methylation; Adult; Biomarkers; Precision Medicine; Temozolomide; Glioblastoma (Gbm); Telomerase Reverse Transcriptase (Tert)
PubMed ID
37417289
Added to directory
Source checked

Report a correction or request removal